Pharmaceutical CDMO Market to Reach USD 353.20 Billion by 2030, Driven by High Demand for Outsourced Drug Development Services

Mordor Intelligence has published a new report on the Pharmaceutical CDMO Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

Pharmaceutical CDMO Market Overview

The pharmaceutical contract development and manufacturing organization (CDMO) market continues to experience strong demand as more pharmaceutical and biotechnology companies turn to third-party service providers to manage drug development and production. The market, valued at USD 258.88 billion in 2025, is expected to reach USD 353.20 billion by 2030, growing at a CAGR of 6.41%. This expansion is largely attributed to increasing R&D activities, the growing complexity of drug formulations, and the need for cost-effective production capabilities.

Pharmaceutical companies are under growing pressure to accelerate time-to-market while maintaining regulatory compliance and managing development risks. CDMOs offer a strategic pathway to meet these demands through comprehensive support, from API synthesis to final dosage formulation and packaging. The market's breadth covers a wide array of services and molecule types, offering scalability and flexibility for companies of all sizes.

Report Overview: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-development-and-manufacturing-organization-cdmo-market?utm_source=openpr

Pharmaceutical CDMO Market Key Trends

Shift Toward Specialized and Biologic Molecules
There is a noticeable increase in demand for CDMOs capable of handling large molecule biologics and high-potency APIs. As the global pharmaceutical pipeline evolves, particularly in oncology and autoimmune disorders, the focus is shifting from traditional small molecules to more specialized, complex therapies. This shift has led to a rise in biologics and biosimilars, which require advanced capabilities in manufacturing, analytical testing, and sterile processing.

Growth in Injectable and Sterile Drug Manufacturing
Injectable dosage forms, particularly sterile injectables, are becoming increasingly popular due to their fast action and higher bioavailability. CDMOs with strong sterile injectable manufacturing capabilities are witnessing higher demand, especially as more therapies require parenteral administration. This includes vaccines, monoclonal antibodies, and long-acting injectables for chronic conditions.

Rising Importance of End-to-End Services
Pharmaceutical companies are favoring CDMOs that offer integrated, end-to-end services-from early-phase development through to commercial-scale manufacturing. This not only streamlines supply chains but also helps manage timelines more effectively. CDMOs with a broad range of services under one roof are increasingly seen as strategic partners rather than just service vendors.

Increased Outsourcing by Small and Mid-Sized Firms
Smaller biotech and pharma firms, often lacking the infrastructure for full-scale production, are increasingly turning to CDMOs to bridge that gap. For these firms, outsourcing is not just about cost-saving-it's essential for bringing their products to market.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/pharmaceutical-contract-development-and-manufacturing-organization-cdmo-market?utm_source=openpr

Pharmaceutical CDMO Market Segmentation:
By Service Type

API Manufacturing

Small Molecule

Large Molecule

High-Potency (HPAPI)

FDF (Finished Dosage Form) Development and Manufacturing

Solid Dose

Liquid Dose

Injectable Dose

Secondary Packaging

By Molecule Type

Small Molecule

Large Molecule (Biologics and Biosimilars)

High-Potency APIs

By Dosage Form

Solid Oral

Sterile Injectables

Topicals and Transdermals

Specialty/Novel (e.g., ODT, Long-acting)

By Therapeutic Area

Oncology

Metabolic and Endocrine

Cardiovascular

CNS and Psychiatry

Infectious Diseases and Vaccines

By Geography

North America

United States

Canada

Mexico

Europe

Germany

United Kingdom

France

Italy

Spain

Russia

Rest of Europe

Asia-Pacific

China

India

Japan

South Korea

Australia and New Zealand

Rest of Asia-Pacific

Middle East and Africa

United Arab Emirates

Saudi Arabia

Turkey

Rest of Middle East

South Africa

Nigeria

Egypt

Rest of Africa

South America

Brazil

Argentina

Rest of South America

Explore Our Full Library of Technology, Media and Telecom Research Industry Reports - https://www.mordorintelligence.com/market-analysis/technology-media-and-telecom?utm_source=openpr

Key Players
Catalent Inc.
Catalent is a global CDMO offering comprehensive services across drug development, delivery technologies, and clinical supply solutions. It has a strong presence in oral, injectable, and biologic dosage forms.

Recipharm AB
Based in Sweden, Recipharm provides pharmaceutical development and manufacturing services to a broad range of global clients. The company specializes in API production and finished dosage forms.

Jubilant Pharmova Ltd
Headquartered in India, Jubilant Pharmova offers contract manufacturing services focused on radiopharmaceuticals, sterile injectables, and allergy therapy products, serving both regulated and emerging markets.

Patheon Inc. (Thermo Fisher Scientific Inc.)
Patheon operates under Thermo Fisher Scientific and is known for its integrated pharmaceutical services, including drug substance and product development, commercial manufacturing, and packaging.

Boehringer Ingelheim Group
Boehringer Ingelheim provides contract development and manufacturing services primarily through its biopharmaceutical division, BioXcellence, focusing on cell culture and microbial systems for biologics production.

Conclusion
The pharmaceutical CDMO market is poised for sustained growth as the pharmaceutical industry continues to adapt to more complex drug development needs and compressed timelines. The growing demand for specialized manufacturing capabilities, such as sterile injectables and high-potency APIs, further underlines the critical role CDMOs play in today's healthcare landscape. As companies strive for efficiency, quality, and speed in product development, strategic partnerships with CDMOs will remain an essential component of their operational model.

Industry Related Reports
Biologics CDMO Market

The Biologics CDMO Market Report is Segmented by Service Type (Process Development, GMP Manufacturing, and More), Type (Mammalian, Microbial), Product Type (Biologics [Monoclonal Antibodies, Recombinant Proteins, and More], Biosimilars), Scale (Pre-Clinical and Clinical, Commercial), End-User (Small/Mid-size Biotech, Large Pharma), and Geography.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/biologics-contract-development-and-manufacturing-organization-cdmo-market?utm_source=openpr

Pharmaceutical Contract Packaging Market

The Pharmaceutical Contract Packaging Market Report is Segmented by Service Type (Primary, Secondary, Tertiary), Packaging Format (Bottles, Vials and Ampoules, and More), Drug Formulation (Solid Dosage, and More), Therapeutic Area (Oncology, Cardiovascular, and More), End-User (Big Pharma, Generics/Biosimilar Companies, and More), and Geography.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-packaging-market?utm_source=openpr

Pharmaceutical Contract Manufacturing Organization (CMO) Market

The Pharmaceutical Contract Manufacturing Organization (CMO) Market report segments the industry into By Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging) and By Geography (North America, Europe, Asia, Australia and New Zealand, Latin America, Middle East and Africa).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-manufacturing-organization-cmo-market?utm_source=openpr

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.